Business Context and Reporting Period
Company: vTv Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 17, 2015
Event: Regulation FD Disclosure regarding an investor presentation delivered on November 17, 2015.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the occurrence of an investor presentation and incorporates the presentation materials by reference as Exhibit 99.1.
Material Changes
No material financial changes or operational updates are detailed within the body of this Form 8-K. The document references an attached investor presentation (Exhibit 99.1) for summary information, but the text of the filing itself contains no comparative data versus prior periods.
Guidance, Outlook, and Risks
Management Commentary: Management presented summary information to existing and potential investors. The Company states it undertakes no duty or obligation to publicly update or revise this information except as required by law.
Legal Status: The information in this report and Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It shall not be incorporated by reference into other filings unless expressly set forth by specific reference.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Investor Presentation dated November 17, 2015) for specific financial data and strategic updates.
- Verify that the summary information in the presentation is considered in the context of the Company's other SEC filings.
- Note that the Company has explicitly disclaimed an obligation to update the information provided in this presentation.
- Confirm the identity of the signatory: Rudy C. Howard, Executive Vice President and Chief Financial Officer.